The Wall Street Journal (1999-2019) The New York Times (since 2023)
Known for
Reporting on Theranos and other corporate scandals
Notable work
Bad Blood: Secrets and Lies in a Silicon Valley Startup
Spouse
Molly Schuetz
Children
3
Awards
Pulitzer Prize (2) George Polk Award Gerald Loeb Award
John Carreyrou (/ˌkæriˈruː/)[1] is a French-American investigative reporter at The New York Times. Carreyrou worked for The Wall Street Journal for 20 years between 1999 and 2019[2] and has been based in Brussels, Paris, and New York City. He won the Pulitzer Prize twice and is well known for having exposed the fraudulent practices of the multibillion-dollar blood-testing company Theranos in a series of articles published in The Wall Street Journal.
^"John Carreyrou: Investigative Reporter". The Wall Street Journal. March 20, 2017. Retrieved January 22, 2019.
^Cartwright, Lachlan (2019-08-29). "'Bad Blood' Author Left Wall Street Journal". Retrieved 2019-11-02.
JohnCarreyrou (/ˌkæriˈruː/) is a French-American investigative reporter at The New York Times. Carreyrou worked for The Wall Street Journal for 20 years...
Silicon Valley Startup (2018), by The Wall Street Journal reporter JohnCarreyrou; an HBO documentary film, The Inventor: Out for Blood in Silicon Valley...
professor John Ioannidis, and later professor of clinical biochemistry Eleftherios Diamandis, along with investigative journalist JohnCarreyrou of The Wall...
2019. Carreyrou, John (May 18, 2018). "Theranos Inc.'s Partners in Blood". The Wall Street Journal. Retrieved April 8, 2019. Carreyrou, John (March 14...
is discussed at length in the book Bad Blood by JohnCarreyrou. In Bad Blood, author JohnCarreyrou concludes there was no evidence of theft by the Fuiszes...
the author JohnCarreyrou with the former medical director of Theranos, exposing Theranos's fraudulent blood testing system. JohnCarreyrou went on to...
According to a 2023 The New York Times investigation by journalist JohnCarreyrou, the production of Conquest was troubled and Rinsch's behavior became...
company whistleblower alongside Tyler Shultz Ebon Moss-Bachrach as JohnCarreyrou, a reporter for The Wall Street Journal who exposes Theranos' fraud...
company's claims are exaggerated." This insight from Diamandis triggered JohnCarreyrou to further investigate the claims that had been made by Theranos. At...
Valley Startup by then The Wall Street Journal investigative reporter JohnCarreyrou is a book about fraud at the blood testing company Theranos. Boies,...
Silicon Valley Startup by The Wall Street Journal investigative reporter JohnCarreyrou, the firm is described as protecting the startup using surveillance...
charges against Holmes for defrauding investors, doctors, and patients. JohnCarreyrou stated "... she ultimately believed that what she was going to achieve...
a Silicon Valley Startup, a 2018 nonfiction book about Theranos by JohnCarreyrou Bad Blood: A Walk Along the Irish Border, a 1987 book by Colm Tóibín...
advocate for Holmes and Theranos. Tyler eventually contacted reporter JohnCarreyrou (who went on to expose the scandal in The Wall Street Journal), but...
sentenced to 12 years in prison. In 2015, a report written by the Journal's JohnCarreyrou alleged that blood testing company Theranos' technology was faulty and...
living Australian". In late 2015, The Wall Street Journal journalist JohnCarreyrou began a series of investigative articles on Theranos, the blood-testing...
was announced on 14 September. The winner was announced 12 November. JohnCarreyrou, Bad Blood: Secrets and Lies in a Silicon Valley Startup James Crabtree...
Charged With Massive Fraud". www.sec.gov. Retrieved August 23, 2020. Carreyrou, John (May 21, 2018). Bad Blood: Secrets and Lies in a Silicon Valley Startup...
Retrieved March 6, 2008. Bacon, John U. (2004). America's Corner Store: Walgreen's Prescription for Success. Hoboken, New Jersey: John Wiley & Sons. ISBN 978-0-471-42617-2...
Medtronic's role in shaping InFuse articles". MinnPost. Retrieved 2013-05-13. JohnCarreyrou & Tom McGinty (2011-06-29). "Medtronic Surgeons Held Back, Study Says"...